Zomedica Pharmaceuticals Set to Start Trading on NYSE

Zomedica Pharmaceuticals (TSXV:ZOM) announced its stock will begin trading on the NYSE American listing on November 21, while retaining its TSXV stock.
As quoted in the press release:

“Today’s announcement marks a major milestone for our company,” stated Zomedica’s Chief Executive Officer Gerald Solensky Jr. “We are excited that the NYSE American listing will provide greater visibility and liquidity for investors in our company.”
“The NYSE is home to the most innovative healthcare and pharmaceutical companies in the world and we welcome Zomedica to our growing community,” said John Tuttle, Global Head of Listings at the New York Stock Exchange. “We look forward to supporting the company’s growth by providing the unique benefits of NYSE American.”

Click here to read the full press release.

Source: globenewswire.com